Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study

R M O'Bryan; John J. Crowley; Paik N. Kim; Robert B. Epstein; Barbara A. Neilan; Charles A. Coltman; W. J. Stuckey; R Pazdur

doi:10.1002/1097-0142(19900215)65:4<856::aid-cncr2820650404>3.0.co;2-6

Back to search

Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study

R M O'Bryan, John J. Crowley, Paik N. Kim, Robert B. Epstein, Barbara A. Neilan

DOI: 10.1002/1097-0142(19900215)65:4<856::aid-cncr2820650404>3.0.co;2-6

Cancer

Data up to Jan 2025

Published1990

Citations25

References4

Fields

Medicine Internal medicine Surgery Oncology

Total Citations Per Year

Abstract

References (4)

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

1985 • 188 citations

Patterns of Resistance and Therapeutic Synergism among Alkylating Agents1

2015 • 133 citations

Antibiotics and Chemotherapy

1978 • 68 citations

A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma

1976 • 8 citations

Cited By (0)

No citing papers found in database